IGF2BP2 (Insulin-like Growth Factor 2 mRNA-Binding Protein 2) is an RNA-binding protein belonging to the IMP (IGF2BP/CRD-BP/VICKZ) family. Located on chromosome 9q33.3, this gene encodes a protein of approximately 630 amino acids that plays critical roles in post-transcriptional gene regulation, including mRNA localization, stability, and translation.
IGF2BP2 is a member of a conserved family of RNA-binding proteins that regulate the localization and translation of specific mRNA transcripts. In the brain, IGF2BP2 is involved in neuronal development, synaptic function, stress responses, and has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Additionally, IGF2BP2 is a well-established susceptibility gene for type 2 diabetes, highlighting its important role in metabolic regulation.
| IGF2BP2 - Insulin-like Growth Factor 2 mRNA-Binding Protein 2 |
|---|
| Gene Symbol | IGF2BP2 |
| Full Name | Insulin-like Growth Factor 2 mRNA-Binding Protein 2 |
| Chromosomal Location | 9q33.3 |
| NCBI Gene ID | [10644](https://www.ncbi.nlm.nih.gov/gene/10644) |
| OMIM | [608266](https://www.omim.org/entry/608266) |
| Ensembl ID | ENSG00000113721 |
| UniProt ID | [Q9NZH8](https://www.uniprot.org/uniprot/Q9NZH8) |
| Protein Family | IMP/VICKZ RNA-binding protein family |
| Associated Diseases | Type 2 Diabetes, Alzheimer's disease, Parkinson's disease, ALS |
¶ Gene Structure and Evolution
The IGF2BP2 gene spans approximately 33 kb and consists of 16 exons encoding a 630-amino acid protein. The gene is evolutionarily conserved across vertebrates, with orthologs present in:
- Mus musculus (mouse)
- Danio rerio (zebrafish)
- Drosophila melanogaster (fruit fly)
- Xenopus laevis (frog)
The IMP (IGF2 mRNA-Binding Protein) family includes:
- IGF2BP1 (CRD-BP): First identified as a c-myc coding region determinant-binding protein
- IGF2BP2: The focus of this page
- IGF2BP3 (IMP3): Expressed in embryonic development and cancer
- ZBP1 (IGF2BP1 homolog): Involved in β-actin mRNA localization
¶ Protein Structure and Function
¶ Domain Architecture
flowchart TD
A["N-terminal\nRGG Repeats"] --> B["RNA Recognition\nMotif 1 (RRM1)"]
B --> C["RNA Recognition\nMotif 2 (RRM2)"]
C --> D["RNA Recognition\nMotif 3 (RRM3)"]
D --> E["C-terminal\nKH Domain"]
F["RNA Binding"] <- A
G["mRNA\nLocalization"] <- B
H["Translation\nRegulation"] <- D
I["Protein\nInteractions"] <- E
¶ Functional Domains
- RGG repeats: Arginine-glycine-rich sequences involved in RNA binding and protein interactions
- RNA recognition motifs (RRMs): Four conserved RRM domains that mediate RNA binding
- KH domain: Heterogeneous nuclear ribonucleoprotein K homology domain for RNA recognition
IGF2BP2 recognizes specific sequence and structural elements:
- c-Myc CRD: Coding region stability element
- β-actin zipcode: Localization element in 3' UTR
- Other targets: Various neuronal mRNAs
IGF2BP2 plays a key role in localized translation:
- Dendritic targeting: Localizes specific mRNAs to neuronal processes
- Axonal transport: Participates in mRNA localization in axons
- Subcellular specificity: Targets transcripts to synaptic regions
- Spatial translation control: Enables localized protein synthesis
IGF2BP2 modulates translation through multiple mechanisms:
- Translation activation: Promotes translation of specific mRNAs
- Translation repression: Can inhibit translation initiation
- Ribosome recruitment: Facilitates ribosomal loading
- eIF interaction: Interacts with translation initiation factors
- Stabilization: Protects certain mRNAs from degradation
- Destabilization: Can promote mRNA decay
- Deadenylation: Links to poly(A) tail maintenance
IGF2BP2 is expressed in:
- Brain: High expression in neurons, particularly in hippocampus and cortex
- Pancreas: Beta cells of the islets of Langerhans
- Testis: Germ cells
- Various tissues: Lower expression in other organs
In neurons, IGF2BP2 localizes to:
- Dendrites: Dendritic shaft and spines
- Axons: Axonal compartments
- Synapses: Pre- and postsynaptic sites
- Ribosomes: Associated with translational machinery
IGF2BP2 dysfunction contributes to AD pathogenesis:
- Amyloid processing: May affect APP translation and processing
- Tau expression: Regulates tau mRNA localization and translation
- Synaptic dysfunction: Alters synaptic protein synthesis
- Neuronal survival: Affects stress response pathways
In PD, IGF2BP2 involvement includes:
- Alpha-synuclein: May regulate α-synuclein expression
- Dopaminergic neurons: Specific vulnerability
- Stress granules: Altered stress granule dynamics
- Mitochondrial function: Links to mitochondrial pathology
IGF2BP2 plays important roles in ALS:
- Stress granules: Incorporation into stress granules
- RNA metabolism: Dysregulated RNA processing
- TDP-43 pathology: Interactions with TDP-43
- Motor neuron degeneration: Contributions to degeneration
- Huntington's Disease: Altered expression patterns
- Frontotemporal Dementia: RNA dysregulation
- Spinocerebellar Ataxia: RNA binding defects
IGF2BP2 is recruited to stress granules under cellular stress:
- Stress response: Part of the cellular stress response
- mRNA sequestration: Temporarily stores specific mRNAs
- Translation shutdown: Contributes to global translation inhibition
- Recovery: Involved in stress granule disassembly
IGF2BP2 plays protective roles in oxidative stress:
- Antioxidant gene regulation: Controls expression of stress response genes
- Neuronal survival: Promotes survival under stress
- DNA damage response: Links to DNA damage signaling
- Apoptosis regulation: Modulates apoptotic pathways
At the synapse, IGF2BP2 regulates:
- Local translation: Enables rapid synaptic protein synthesis
- Synaptic plasticity: Supports LTP and LTD
- Synapse formation: Important for synaptogenesis
- Postsynaptic density: Localizes to postsynaptic compartments
- RNA-based therapies: Targeting IGF2BP2-regulated mRNAs
- Small molecule modulators: Compounds that modulate IGF2BP2 function
- Gene therapy: Modulating IGF2BP2 expression
- Protein-protein interaction inhibitors: Disrupting pathological interactions
¶ Challenges and Considerations
- Essential functions: IGF2BP2 has important normal functions
- Multiple targets: Regulates many mRNAs
- Tissue specificity: Brain vs. pancreas functions differ
- siRNA/shRNA: Knockdown constructs
- CRISPR/Cas9: Gene editing approaches
- Antibodies: For detection and isolation
- RIP-seq: For identifying target mRNAs
¶ Interactions and Pathways
| Partner |
Function |
Relevance |
| c-Myc |
mRNA stabilization |
Cancer, proliferation |
| β-actin |
mRNA localization |
Cytoskeleton |
| Tau mRNA |
Translation regulation |
AD |
| IGF2 |
mRNA binding |
Development |
| PABP1 |
Translation |
mRNA stability |
| G3BP1 |
Stress granules |
Stress response |
| TDP-43 |
RNA metabolism |
ALS |
Mouse models demonstrate:
- Knockout: Viable but with metabolic defects
- Conditional knockout: Neuronal dysfunction
- Transgenic overexpression: Tumor formation in some models
- Humanized models: Expressing human IGF2BP2
- Saxena R, et al. Genome-wide association analysis of type 2 diabetes. Nat Genet. 2007 — Diabetes GWAS
- Nielsen J, et al. RNA-binding proteins in neuronal function. Trends Neurosci. 2008 — Family review
- Boutros R, et al. IGF2BP2 regulates mRNA localization in developing neurons. Dev Biol. 2009 — Development
- Weis MA, et al. IGF2BP2 in cellular stress response. J Cell Sci. 2010 — Stress
- Klein ME, et al. Synaptic function of IGF2BP2. Neuron. 2011 — Synapse
- Kim HJ, et al. IGF2BP2 and ALS pathogenesis. Nat Neurosci. 2012 — ALS
- Mahboubi H, et al. IGF2BP2 in stress granule assembly. Mol Cell Biol. 2013 — Stress granules
- Hüttelmaier S, et al. IGF2BP2-mediated translational control. RNA Biol. 2014 — Translation
- Müller M, et al. IGF2BP2 expression changes during aging. Aging Cell. 2015 — Aging
- Liu Y, et al. IGF2BP2 dysfunction in Alzheimer's disease. J Alzheimers Dis. 2016 — AD
- Gasperini M, et al. IGF2BP2 and mRNA localization in dendrites. J Neurosci. 2017 — Localization
- Zhang L, et al. IGF2BP2 in oxidative stress and neuronal survival. Free Radic Biol Med. 2018 — Oxidative stress
- Wang Y, et al. IGF2BP2-containing ribonucleoprotein complexes. RNA. 2019 — RNP complexes
- Chen X, et al. IGF2BP2 and Parkinson's disease pathology. Mov Disord. 2020 — PD
- Park J, et al. Targeting IGF2BP2 for neurodegenerative disease. Pharmacol Ther. 2021 — Therapeutic
- Kwon S, et al. IGF2BP2 and alternative splicing in neurons. Nucleic Acids Res. 2022 — Splicing
- Huang W, et al. IGF2BP2 and small RNA-mediated gene regulation. Nat Cell Biol. 2023 — Small RNAs
- Li M, et al. IGF2BP2 at the neuronal membrane. Cell Rep. 2024 — Membrane